1Nazir S, Hussain T, Ayub A, Rashid U, MacRobert AJ (2014) Nanomaterials in combating cancer: Therapeutic applications and developments. Nanomedicine 10: 19–34.

2Singec I, Jandial R, Crain A, Nikkhah G, Snyder EY (2007) The leading edge of stem cell therapeutics. Annu Rev Med 58: 313-328.

3Bianco P, Riminucci M, Gronthos S, Robey PG (2001) Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19: 180-192.

4Caplan AI, Bruder SP (2001) Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 7: 259-264.

5Hu CM, Aryal S, Zhang L (2010) Nanoparticle-assisted combination therapies for effective cancer treatment. Ther Deliv 1: 323–334.

6Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46: 6387–6392.

7Northfelt DW, Dezube BJ, Thommes JA, Miller BJ, Fischl MA, et al. (1998) PEGylated-liposomal doxorubicin versus doxorubicin, bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. J Clin Oncol 16: 2445–2451.

8Harries M, Ellis P, Harper P (2005) Nanoparticle albumin-bound paclitaxel for metastatic breast cancer. J Clin Oncol 23: 7768–7771.

9Pathak P, Katiyar VK, Giri S (2007) Cancer Research - Nanoparticles, Nanobiosensors and Their Use in Cancer Research. Journal of Nanotechnology Online 14.

10Pathak P, Katiyar VK (2007) Multi-Functional Nanoparticles and Their Role in Cancer Drug Delivery – A Review. Virus 30.

11Brigger I, Dubernet C, Couvreur P (2002) Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 54: 631-651.

12Bharali DJ, Khalil M, Gurbuz M, Simone TM, Mousa SA (2009) Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers. Int J Nanomedicine 4: 1-7.

13Liechty WB, Peppas NA (2011) Expert opinion: Responsive polymer nanoparticles in cancer therapy. Eur J Pharm Biopharm 80: 241-246.

14Brannon-Peppas L, Blanchette JO (2004) Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56: 1649-1659.

15Cho K, Wang X, Nie S, Chen ZG, Shin DM (2008) Therapeutic Nanoparticles for Drug Delivery in Cancer. Clin Cancer Res 14: 1310-1316.

16Jain S, Hirst DG, O'Sullivan JM (2012) Gold nanoparticles as novel agents for cancer therapy. Br J Radiol 85: 101–113.

17Prashant K Jain, Ivan H El-Sayedb, Mostafa A El-Sayed (2007) Au nanoparticles target cancer. Nano Today 2: 18-29.

18Lu W (2012) Nanoparticles for Cancer Treatment. Biomedical and Pharmaceutical Sciences 95: 294-295.

19Bhattacharyya S, Kudgus RA, Bhattacharya R, Mukherjee P (2011) Inorganic nanoparticles in cancer therapy. Pharm Res 28: 237-259.

20Wang X, Yang L, Chen ZG, Shin DM (2008) Application of Nanotechnology in Cancer Therapy and Imaging. CA Cancer J Clin 58: 97-110.

21Praetorius NP, Mandal TK (2007) Engineered Nanoparticles in Cancer Therapy. Recent Pat Drug Deliv Formul. 1: 37-51.

22Yu MK, Park J, Jon S (2012) Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy. Theranostics 2: 3-44.

23Siew A (2013) Nanoparticles: Facilitating targeted delivery in cancer therapy. Pharma Techn Europe 37: 48-52.

24Sukumar U, Bhushan B, Dubey P, Matai I, Sachdev A, et al. (2013) Emerging Applications of Nanoparticles for Lung Cancer Diagnosis and Therapy. Inter Nano Lett 3: 1-17.

25Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AS, et al. (2003) Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans - Histological analysis of cell survival and differentiation. J Am Coll Cardiol 41: 879- 888.

26Sharma P, Brown S, Walter G, Santra S, Moudgil B (2006) Nanoparticles for bioimaging. Adv Colloid Interface Sci 123: 471-485.

27Alivisatos AP (1996) Semiconductor clusters, nano- crystals, and quantum dots. Science; 271: 933-937.

28Voura EB, Jaiswal JK, Mattoussi H, Simon SM (2004) Tracking metastatic tumor cell extravasa- tion with quantum dot nanocrystals and fluo- rescence emission-scanning microscopy. Nat Med 10: 993-998.

29Wang F, Tan WB, Zhang Y, Fan XP, Wang MQ (2006) Luminescent nanomaterials for biological labelling. Nanotechnology 17: R1-R13.

30Brijmohan SB, Swier S, Weiss RA, Shaw MT (2005) Synthesis and characterization of cross- linked sulfonated polystyrene nanoparticles. Ind Eng Chem 44: 8039-8045.

31Wang F, Banerjee D, Liu YS, Chen XY, Liu XG (2010) Upconversion nanoparticles in biological labeling, imaging, and therapy. Analyst 135: 1839-1854.

32Harkness L, Novikov SM, Beermann J, Bozhevolnyi SI, Kassem M (2012) Identification of abnormal stem cells using Raman spectroscopy. Stem Cells Dev 21: 2152-2159.

33Jorio A, Saito R, Dresselhaus G, Dressel- haus MS (2004) Determination of nanotubes properties by Raman spectroscopy. Philos Trans A Math Phys Eng Sci 362: 2311- 2336.

34Burns A, Ow H, Wiesner U (2006) Fluorescent core-shell silica nanoparticles: towards "Lab on a Particle" architectures for nanobiotechnology. Chem Soc Rev 35: 1028-1042.

35Ow H, Larson DR, Srivastava M, Baird BA, Webb WW, et al. (2005) Bright and stable core-shell fluorescent silica nanoparticles. Nano Lett 5: 113-117.

36Brijmohan SB, Swier S, Weiss RA, Shaw MT (2005) Synthesis and characterization of cross- linked sulfonated polystyrene nanoparticles. Ind Eng Chem 44: 8039-8045.

37Thakor AS, Jokerst J, Zavaleta C, Massoud TF, Gambhir SS. (2011) Gold nanoparticles: A revival in precious metal administration to patients. Nano Lett 11: 4029-4036.

38Haase M, Schafer H (2011) Upconverting Nanoparticles. Angewandte Chemie International Edition 50: 5808-5829.

39Wang M, Abbineni G, Clevenger A, Mao CB, Xu SK. (2011) Upconversion nanoparticles: synthesis, surface modification and biological applications. Nanomedicine 7: 710-729.

40Nam SY, Ricles LM, Suggs LJ, Emelianov SY (2012) In vivo ultrasound and photoacousticmoni- toring of mesenchymal stem cells labeled with gold nanotracers. PloS One 7: e37267.

41Harkness L, Novikov SM, Beermann J, Bozhev- olnyi SI, Kassem M. (2012) Identification of abnormal stem cells using Raman spectroscopy. Stem Cells Dev 21: 2152-2159.

42Jorio A, Saito R, Dresselhaus G and Dressel- haus MS. (2004) Determination of nanotubes proper- ties by Raman spectroscopy. Philos Trans R Soc London 362: 2311- 2336.

43LaConte L, Nitin N, Bao G (2005) Magnetic nanoparticle probes. Mater Today 8: 32–38.

44 Reimer P, Balzer T (2003) Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 13: 1266–1276.

45 Rogers WJ, Basu P (2005) Factors regulating macrophage endocytosis of nanoparticles: implications for targeted magnetic resonance plaque imaging. Atherosclerosis 178: 67–73.

46Guzman R, Uchida N, Bliss TM, He D, Christopherson KK, et al. (2007) Long-term monitoring of transplanted human neural stem cells in developmental and patho- logical contexts with MRI. Proc Natl Acad Sci U S A 104: 10211–10216.